Ignite Creation Date:
2025-12-24 @ 11:33 PM
Ignite Modification Date:
2026-01-03 @ 7:25 AM
Study NCT ID:
NCT00988156
Status:
COMPLETED
Last Update Posted:
2018-11-13
First Post:
2009-10-01
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Eslicarbazepine Acetate (BIA 2 093) as Therapy for Refractory Partial Seizures in Children
Sponsor:
Bial - Portela C S.A.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-12-07
Start Date Type:
ACTUAL
Primary Completion Date:
2012-08-20
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-08-24
Completion Date Type:
ACTUAL
First Submit Date:
2009-10-01
First Submit QC Date:
None
Study First Post Date:
2009-10-02
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-05-09
Results First Submit QC Date:
None
Results First Post Date:
2014-07-17
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-10-12
Last Update Post Date:
2018-11-13
Last Update Post Date Type:
ACTUAL